BEOVU
brolucizumab
Listed by Novartis Pharmaceuticals Corporation
- Strength
- 6 mg/.05mL
- Form
- Injection, Solution
- Route
- Intravitreal
What it contains
- Brolucizumab 6 mg/.05mL
FDA record
| Dosage form | Injection, Solution |
|---|---|
| Route | Intravitreal |
| Approval route | BLA — biologic licence |
| NDC code | 0078-0827 |
| FDA application | BLA761125 |
| RxNorm concept | 2204920 |
| Package sizes listed | 2 |
| Marketed since | October 2019 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.